Biomarker composition for diagnosing Alzheimer's dementia and use thereof

The present invention relates to a biomarker composition for diagnosing Alzheimer′s dementia and a use thereof. By a composition, a kit, and a method according to one embodiment, early diagnosis of Alzheimer′s dementia is possible with high accuracy using a blood sample. Accordingly, the present inv...

Full description

Saved in:
Bibliographic Details
Main Authors LEE KUN HO, KIM BYEONG CHAE, LIM DO SUNG, CHO YEONG HEE, PARK JUNG EUN, LEE JUNG SUP
Format Patent
LanguageEnglish
Korean
Published 10.03.2020
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a biomarker composition for diagnosing Alzheimer′s dementia and a use thereof. By a composition, a kit, and a method according to one embodiment, early diagnosis of Alzheimer′s dementia is possible with high accuracy using a blood sample. Accordingly, the present invention can be expected to be applied as a core technology in the field of Alzheimer′s dementia diagnosis. 알츠하이머성 치매 진단용 바이오마커 조성물 및 이의 용도에 관한 것이다. 일 실시예에 따른 조성물, 키트, 및 방법에 의하면, 혈액 샘플을 이용하여 알츠하이머성 치매를 높은 정확도로 조기 진단이 가능하므로, 알츠하이머성 치매 진단 분야의 핵심 기술로 응용될 수 있을 것으로 기대된다.
Bibliography:Application Number: KR20180102177